On Aug. 4, the FTC and DOJ’s Antitrust Division announced a 30-day extension of the deadline for public comment on proposed changes to the premerger notification form and associated instructions, as well as the premerger notification rules implementing the Hart-Scott-Rodino (HSR) Act. With the extension, the agencies will be accepting comments on the proposed changes until Sept. 27, 2023, extended from the original deadline of Aug. 28.
2. |
|
FTC approves consent order preventing entanglements between Quantum Energy Partners and EQT Corporation. |
On Aug. 16, the FTC resolved antitrust concerns surrounding a $5.2 billion cash-and-stock deal between private equity firm Quantum Energy Partners and natural gas producer EQT Corporation by approving a consent order that prevents entanglements between the two companies and the exchange of confidential, competitively sensitive information. Quantum and EQT are direct competitors in the production and sale of natural gas in the Appalachian Basin, the largest natural gas-producing region in the United States. The proposed acquisition would have made Quantum one of EQT’s largest shareholders and give Quantum – an active investor in natural gas production in the region – a seat on EQT’s board of directors, violating the antitrust laws and harming competition in this industry, according to the FTC. The FTC consent order would resolve the Commission’s competition concerns through provisions that, among other things, would:
- Prohibit Quantum from serving on EQT’s Board for the duration of the order and on the Board of any of the top seven Appalachian Basin natural gas producers, which account for a substantial majority of the market, without prior Commission approval.
- Require Quantum to sell its EQT shares by a non-public date certain.
- Require that during the period when Quantum owns EQT shares, the shares will be held in a voting trust, and any votes will be carried out by the trustee proportional to all other EQT shareholders.
3. |
|
Henry Liu appointed to serve as director of FTC’s Bureau of Competition. |
On Aug. 22, FTC Chair Lina M. Khan appointed Henry Liu to serve as director of the FTC’s Bureau of Competition. Liu joins the FTC from a private practice law firm, where he was a partner in the firm’s litigation and antitrust practices, bringing more than 14 years of experience litigating complex antitrust cases. Previously, Liu served as a law clerk to the Honorable R. Guy Cole, Jr. of the U.S. Court of Appeals for the Sixth Circuit.
4. |
|
FTC and DOJ to co-host new merger guidelines workshops. |
On Aug. 28, the FTC and Justice Department announced they are co-hosting three workshops to facilitate public dialogue on the new Merger Guidelines, which were announced in July. See GT Alert.
The workshops aim to promote a dynamic discussion about the draft guidelines to complement the public comments currently being submitted to the agencies. The goal of the merger guidelines update is to better reflect how the agencies determine a merger’s effect on competition in the modern economy and evaluate proposed mergers under the law. The first workshop was held online Sept. 5, with subsequent workshop dates to be announced.
5. |
|
FTC approves consent order with ICE and Black Knight to resolve antitrust concerns. |
On Aug. 31, the FTC approved a proposed consent order to resolve antitrust concerns surrounding Intercontinental Exchange, Inc. (ICE)’s proposed $13.1 billion acquisition of Black Knight, Inc. The proposed settlement ensures Black Knight’s divestiture of Empower and Optimal Blue, two businesses that provide critical services in the mortgage origination process. The FTC also secured other concessions to promote the success of the divested businesses.
B. |
|
Department of Justice (DOJ)
|
1. |
|
Two Pinterest Directors resign from Nextdoor Board of Directors in response to Justice Department’s enforcement efforts around Section 8 of the Clayton Act. |
On Aug. 16, the Antitrust Division announced that two directors of Pinterest Inc. resigned their positions on the Board of Directors of Nextdoor Holdings Inc. in response to the Division’s ongoing efforts around Section 8 of the Clayton Act. To date, the Division’s enforcement initiative has led to 15 interlocking director resignations from 11 boards. Nextdoor is a large social network that connects users, businesses, and other neighborhood stakeholders, and Pinterest is a leading social network and image sharing service. Both are Delaware corporations headquartered in San Francisco.
2. |
|
Asphalt paving company and two executives plead guilty to rid rigging. |
On Aug. 17, the Division announced that a senior executive of a Michigan asphalt paving company pleaded guilty in the U.S. District Court in Detroit for his role in two separate conspiracies to rig bids for asphalt paving services contracts in the state of Michigan.
According to court documents filed in the case, Kevin Shell, vice president of Estimating for Clarkston-based F. Allied Construction Company Inc., conspired with two unnamed asphalt paving companies and their employees to rig bids in each other’s favor. Shell participated in the two conspiracies from June 2013 through June 2019, and from July 2017 through May 2021, respectively.
On Aug. 29, the Division announced that Allied and its president, Andrew Foster, pleaded guilty to conspiring with two asphalt paving companies and their employees to rig bids in each other’s favor. Allied and Foster participated in the two conspiracies from June 2013 through June 2019, and from July 2017 through May 2021, respectively. The co-conspirators coordinated each other’s bid prices so that the agreed-upon losing company would submit intentionally non-competitive bids. These bids gave customers the false impression of competition when, in fact, the co-conspirators already had decided among themselves who would win the contracts.
3. |
|
Two Military Contractors sentenced for bid rigging in Eastern District of Texas. |
On Aug. 23, the Division announced that two military contractors were sentenced in the U.S. District Court for the Eastern District of Texas, Texarkana Division, for their roles in a bid-rigging scheme involving the maintenance and repair of military tactical vehicles in Texas. The multi-year scheme secured more than $17 million in taxpayer dollars.
Aaron Stephens of Queen City, Texas was sentenced to 18 months in prison and ordered to pay a criminal fine of $50,000. According to a plea agreement filed Jan. 12, Stephens and his co-conspirators rigged bids on certain government contracts from May 2013 to January 2018 to give the false impression of competition and secure government payments. The conspirators submitted coordinated, higher-priced and non-competitive bids to ensure a designated company won each contract. Stephens and his co-conspirators rigged six different contracts for work performed for the Red River Army Depot in Texarkana, Texas. The projects included heavy military equipment work like refurbishing armor kits for military trucks and turrets for Humvees.
John “Mark” Leveritt of Heath, Texas was sentenced to six months in prison and ordered to pay a criminal fine of $300,000. According to a July 13, 2022, plea agreement, Leveritt engaged in the same conspiracy from May 2013 to April 2018 involving seven bids.
4. |
|
Doctor pleads guilty to antitrust conspiracy to allocate oncology treatments for cancer patients in Southwest Florida. |
On Aug. 24, the Division announced that a medical oncologist and former president and managing partner of Florida Cancer Specialists & Research Institute LLC (FCS) pleaded guilty to conspiracy to allocate oncology treatments for cancer patients in Southwest Florida.
According to court documents filed in the U.S. District Court in Ft. Myers, Florida, Dr. William Harwin participated in a conspiracy from 1999 to September 2016 to suppress competition by agreeing to allocate chemotherapy treatments for cancer patients to FCS and radiation treatments to another oncology company in Lee, Collier, and Charlotte Counties. Harwin pleaded guilty to one count of violating Section One of the Sherman Act.
1. |
|
Jacob Fabel, et al. v. Boardwalk 1000, LLC d/b/a Hard Rock Hotel & Casino Atlantic City, et al., Case No. 1:23-cv-06576 (D.N.J.) |
In an Aug. 21 proposed class-action complaint, plaintiff Jacob Fabel alleges that several New Jersey Casino-Hotels forced guests to pay artificially inflated room rates after conspiring to switch from occupancy-driven pricing to a revenue-increasing model. Specifically, plaintiff complains that an algorithm provided by a platform called Rainmaker generated room rates that helped the casino-hotel defendants rebound from the COVID-19 pandemic and generate revenue in 2021 that far exceeded their pre-pandemic profits. Plaintiff claims that the algorithm used information from a variety of sources, including room rates provided by the casino-hotels themselves, to recommend prices that would maximize revenue instead of occupancy rates. Plaintiff claims that defendant Cendyn Group, which acquired Rainmaker in 2019, advised its customers to “not chas[e] after occupancy growth” and “avoid the infamous ‘race to the bottom.’”
Plaintiff alleges that the conspiracy is an unlawful restraint of trade in violation of Section 1 of the Sherman Act. He claims that the conspiracy began in 2018 and that it caused plaintiff and other similarly situated to pay artificially inflated prices directly to the casino-hotels and their co-conspirators. Plaintiff has characterized the alleged conspiracy as a “hub-and-spoke conspiracy in which Rainmaker . . . served as the hub and individual Casino-Hotel Defendants served as spokes.” In furtherance of the conspiracy, plaintiff claims that: (a) “Casino-Hotel Defendants provided internal pricing and supply data to a single-third-party… for use in the Rainmaker algorithm”; (b) “Rainmaker, and later Cendyn, sold and operated the Rainmaker pricing algorithm platform that provided room pricing recommendations to the Casino-Hotel Defendants”; (c) “Casino-Hotel Defendants knowingly used the same pricing algorithm platform that incorporated pricing and supply data from other Casino-Hotel Defendants in recommending optimal room rates” to charge guests; (d) “Casino-Hotel Defendants priced their rooms pursuant to the optimal rates the Rainmaker pricing algorithm platform recommended”; (e) “Defendants exchanged competitively sensitive pricing and supply information with each other”; and (f) Defendants engaged in various forms of information-sharing “that had the purpose and effect of maintaining and reinforcing their anticompetitive scheme.” Plaintiff further claims that the casino-hotel defendants possess market power in the relevant market and that the alleged conspiracy led to “anticompetitive effects in the form of supra-competitive prices Plaintiff and other Class members have paid directly to the Casino-Hotel Defendants.”
2. |
|
Jacksonville Police Officers and Fire Fighters Health Ins. Trust v. Gilead Sciences, Inc., et al., Case No. 20-cv-06522-JSW (N.D. Cal.) |
On Aug. 28, U.S. District Judge Jeffrey S. White granted defendants’ motion to dismiss plaintiffs’ second amended class action complaint but granted plaintiffs final leave to amend. In their second amended complaint, plaintiffs claim that defendants entered into anticompetitive reverse-payment settlement agreements to protect Gilead’s patents on its brand name drugs. Plaintiffs assert they were injured because defendants’ conduct allegedly kept a co-packaged, generic version of Truvada, an HIV medication, off the market. Defendants moved to dismiss, arguing that plaintiffs’ allegations are still speculative. In support of their second amended complaint, plaintiffs allege that the generic drug manufacturer, Cipla, “never sought approval from the FDA to market a co-packaged emtricitabine/TDF product ‘despite strong indications from the FDA that such an application would be approved.’”
Plaintiffs also allege that the FDA “‘encourage[d] sponsors to submit applications… for approval of fixed dose combination… and co-packaged versions of previously approved’ HIV drugs, that those products would be eligible for priority review, and that even if individual drugs were still protected by a patent, the FDA could ‘grant tentative approval so that [a] fixed-dose combination or co-packaged configuration could be marketed as soon as’ a patent expired.” Despite these indications, however, plaintiffs claim Cipla failed to file an abbreviated new drug application (ANDA) on Truvada, while choosing to file ANDAs for the drugs Viread and Emtriva. In granting the motion to dismiss, the court explained that “[a]lthough Plaintiffs have provided greater factual support for the allegation that FDA approval of a co-packaged version of Truvada was ‘virtual certainty,’ . . . their allegations about whether Cipla, or any other generic manufacturer, intended to seek approval for a co-packaged version of Truvada are based on speculation and conjecture and are insufficient to plausibly allege their theory of injury.” However, because the court could not “say it would be futile” for plaintiffs to amend the complaint, the court granted plaintiffs one final opportunity to amend.
|